Synergy Pharmaceuticals (SGYP) Leaps on FDA Nod

Synergy Pharmaceuticals Inc

shares rose 6.9% to $3.56 after the company reported the NDA acceptance for Plecanatide by the FDA. Share volume was 5.5 million, compared to an all-day average of 2.5 million